The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $48.49

Today's change+0.39 +0.81%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $48.49

Today's change+0.39 +0.81%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA up (U.S.)$0.39

Fresenius Medical Care AG & Co KGaA closed up Wednesday by (U.S.)$0.39 or 0.81% to (U.S.)$48.49. Over the last five days, shares have gained 0.48% and are currently 3.44% off of the 52-week high. Shares have underperformed the S&P 500 by 3.65% during the last year.

Key company metrics

  • Open(U.S.) $48.51
  • Previous close(U.S.) $48.10
  • High(U.S.) $48.55
  • Low(U.S.) $48.29
  • Bid / Ask(U.S.) $48.44 / (U.S.) $48.51
  • YTD % change+14.88%
  • Volume93,282
  • Average volume (10-day)145,061
  • Average volume (1-month)189,046
  • Average volume (3-month)166,444
  • 52-week range(U.S.) $38.05 to (U.S.) $50.22
  • Beta0.46
  • Trailing P/E20.45×
  • P/E 1 year forward20.50×
  • Forward PEG2.01×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.09%
  • Trailing EPS(U.S.) $2.37
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.22%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue4,4714,5483,8953,821
Total other revenue--------
Total revenue4,4714,5483,8953,821
Gross profit1,4951,5921,3231,223
Total cost of revenue2,9762,9562,5722,598
Total operating expense3,8883,8973,2423,265
Selling / general / administrative900923617657
Research & development35323536
Depreciation / amortization00----
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income583651653557
Interest income (expense), net non-operating-89-121-88-91
Gain (loss) on sale of assets--------
Other--------
Income before tax488559572474
Income after tax338377396337
Income tax, total151182176136
Net income269308323277
Total adjustments to net income--------
Net income before extra. items269308323277
Minority interest-69-69-73-60
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items269308323277
Inc. avail. to common incl. extra. items269308323277
Diluted net income269308323277
Dilution adjustment----00
Diluted weighted average shares307306307307
Diluted EPS excluding extraordinary itemsvalue per share0.881.011.050.90
Dividends per sharevalue per share0.000.00----
Diluted normalized EPSvalue per share0.881.011.050.90